Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,084,826
  • Shares Outstanding, K 54,075
  • Annual Sales, $ 110,320 K
  • Annual Income, $ -70,690 K
  • EBIT $ -69 M
  • EBITDA $ -78 M
  • 60-Month Beta 0.25
  • Price/Sales 36.87
  • Price/Cash Flow N/A
  • Price/Book 8.37

Options Overview Details

View History
  • Implied Volatility 50.71% ( -1.54%)
  • Historical Volatility 59.25%
  • IV Percentile 14%
  • IV Rank 12.25%
  • IV High 105.37% on 11/04/24
  • IV Low 43.07% on 08/28/24
  • Put/Call Vol Ratio 36.00
  • Today's Volume 37
  • Volume Avg (30-Day) 847
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 35,310
  • Open Int (30-Day) 37,979

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.53
  • Number of Estimates 8
  • High Estimate -0.01
  • Low Estimate -0.88
  • Prior Year 0.42
  • Growth Rate Est. (year over year) -226.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.39 +2.94%
on 12/19/24
96.39 -21.63%
on 12/03/24
-11.68 (-13.39%)
since 11/20/24
3-Month
73.33 +3.01%
on 10/03/24
107.37 -29.65%
on 11/12/24
-11.07 (-12.78%)
since 09/20/24
52-Week
47.88 +57.77%
on 05/10/24
107.37 -29.65%
on 11/12/24
+24.88 (+49.11%)
since 12/20/23

Most Recent Stories

More News
Stocks Under Pressure from Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.12%. Stocks today are slightly...

APO : 171.03 (+0.83%)
BABA : 82.28 (-2.41%)
NVDA : 134.70 (+3.08%)
IPG : 29.07 (+1.54%)
OMC : 88.86 (+1.92%)
$SPX : 5,930.85 (+1.09%)
BIOA : 6.14 (+18.76%)
SMCI : 31.59 (+1.12%)
BIDU : 85.80 (+0.26%)
FTV : 74.45 (+1.65%)
$IUXX : 21,289.15 (+0.85%)
WDAY : 273.04 (+2.33%)
Insider Sale: Director at $ACLX (ACLX) Sells 300 Shares

Kavita Patel, a director at $ACLX ($ACLX), sold 300 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares....

ACLX : 75.54 (+0.44%)
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies

/CNW/ -- USA News Group – Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase...

ONCY : 0.8310 (-6.36%)
ACLX : 75.54 (+0.44%)
ONC.TO : 1.19 (-9.16%)
GTHX : 7.15 (unch)
HALO : 46.96 (-0.76%)
SNY : 47.71 (+0.44%)
2 Potential Stocks to Buy From Barchart’s ‘Death Cross’ Indicator

While a security’s short-term moving average dipping below its long-term average warrants caution, this dynamic may also be a contrarian indicator.

IRTC : 90.39 (+3.11%)
ACLX : 75.54 (+0.44%)
Chart of the Day: Arcellx - Reimagining Cell Therapy

The Chart of the Day belongs to the immunotherapy company Arcellx (ACLX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

ACLX : 75.54 (+0.44%)
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 75.54 (+0.44%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 75.54 (+0.44%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 75.54 (+0.44%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 75.54 (+0.44%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 75.54 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 79.84
2nd Resistance Point 78.13
1st Resistance Point 76.83
Last Price 75.54
1st Support Level 73.82
2nd Support Level 72.11
3rd Support Level 70.81

See More

52-Week High 107.37
Fibonacci 61.8% 84.64
Fibonacci 50% 77.62
Last Price 75.54
Fibonacci 38.2% 70.61
52-Week Low 47.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar